Literature DB >> 10702269

cAMP response element-binding protein-binding protein binds to human papillomavirus E2 protein and activates E2-dependent transcription.

D Lee1, B Lee, J Kim, D W Kim, J Choe.   

Abstract

cAMP response element-binding protein-binding protein (CBP) is a eucaryotic transcriptional co-activator that contains multiple protein-protein interaction domains for association with various transcription factors, components of the basal transcriptional apparatus, and other co-activator proteins. Here, we report that CBP is also a co-activator of the human papillomavirus (HPV) E2 protein, which is a sequence-specific transcription/replication factor. We provide biochemical, genetic, and functional evidence that CBP binds directly to HPV E2 in vivo and in vitro and activates E2-dependent transcription. Mutations in an amphipathic helix within HPV-18 E2 abolish its transcriptional activation properties and its ability to bind to CBP. Furthermore, the binding of CBP to E2 was shown to be necessary for E2-dependent transcription. Interestingly, the histone acetyltransferase activity of CBP plays a role in CBP activation of E2-dependent transcription.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10702269     DOI: 10.1074/jbc.275.10.7045

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis.

Authors:  T Seo; J Park; D Lee; S G Hwang; J Choe
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  The E2 protein of human papillomavirus type 8 increases the expression of matrix metalloproteinase-9 in human keratinocytes and organotypic skin cultures.

Authors:  Baki Akgül; Ramón García-Escudero; Christine Ekechi; Gertrud Steger; Harshad Navsaria; Herbert Pfister; Alan Storey
Journal:  Med Microbiol Immunol       Date:  2011-01-28       Impact factor: 3.402

3.  The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity.

Authors:  J Park; T Seo; S Hwang; D Lee; Y Gwack; J Choe
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300.

Authors:  Andreas Müller; Andreas Ritzkowsky; Gertrud Steger
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  Direct interaction between nucleosome assembly protein 1 and the papillomavirus E2 proteins involved in activation of transcription.

Authors:  Manuela Rehtanz; Hanns-Martin Schmidt; Ursula Warthorst; Gertrud Steger
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

6.  Identification of a novel p300-specific-associating protein, PRS1 (phosphoribosylpyrophosphate synthetase subunit 1).

Authors:  Atsushi Kaida; Yasuo Ariumi; Keiko Baba; Masami Matsubae; Toshifumi Takao; Kunitada Shimotohno
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

7.  Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin.

Authors:  Maria G McPhillips; Keiko Ozato; Alison A McBride
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

8.  Association of bovine papillomavirus E2 protein with nuclear structures in vivo.

Authors:  Reet Kurg; Kristiina Sild; Aigi Ilves; Mari Sepp; Mart Ustav
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

9.  Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death.

Authors:  Taegun Seo; Daeyoup Lee; Young Sam Shim; Jon E Angell; Natesa V Chidambaram; Dhananjaya V Kalvakolanu; Joonho Choe
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 10.  Viral manipulation of the host epigenome for oncogenic transformation.

Authors:  Roberto Ferrari; Arnold J Berk; Siavash K Kurdistani
Journal:  Nat Rev Genet       Date:  2009-05       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.